A nonsense mutation in the cathepsin K gene observed in a family with pycnodysostosis

被引:99
作者
Johnson, MR
Polymeropoulos, MH
Vos, HL
deLuna, RIO
Francomano, CA
机构
[1] NIH,NATL CTR HUMAN GENOME RES,MED GENET BRANCH,BETHESDA,MD 20892
[2] NIH,NATL CTR HUMAN GENOME RES,LAB GENET DIS RES,BETHESDA,MD 20892
[3] NETHERLANDS CANC INST,AMSTERDAM,NETHERLANDS
[4] HOSP INFANTIL MEXICO DR FEDERICO GOMEZ,MEXICO CITY,DF,MEXICO
来源
GENOME RESEARCH | 1996年 / 6卷 / 11期
关键词
BONE-RESORPTION; MOLECULAR-CLONING; CYSTEINE PROTEINASES; OSTEOCLASTOMAS; ORGANIZATION; INHIBITION;
D O I
10.1101/gr.6.11.1050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pycnodysostosis (MIM 265800) is a rare, autosomal recessive skeletal dysplasia characterized by short stature, wide cranial sutures, and increased bone density and fragility. Linkage analysis localized the disease gene to human chromosome 1q21, and subsequently the genetic interval was narrowed to between markers D1S2612 and D1S2345. Expressed sequence tagged markers corresponding to cathepsin K, a cysteine protease highly expressed in osteoclasts and thought to be important in bone resorption, were mapped previously in the candidate region. We have identified a cytosine to thymidine transition at nucleotide 862 (GenBank accession no. S79895) of the cathepsin K coding sequence in the DNA of an affected individual from a large, consanguinous Mexican family. This mutation results in all arginine to STOP alteration at amino acid 241, predicting premature termination of cathepsin K mRNA translation. All affected individuals in this Family were homozygous for the mutation, suggesting that this alteration may lead to pycnodysostosis. Recognition of the role of cathepsin K in the etiology of pycnodysostosis should provide insights into the pathogenesis and treatment of other disorders of bone remodeling, including osteoporosis.
引用
收藏
页码:1050 / 1055
页数:6
相关论文
共 26 条
[1]   Proteolytic activity of human osteoclast cathepsin K - Expression, purification, activation, and substrate identification [J].
Bossard, MJ ;
Tomaszek, TA ;
Thompson, SK ;
Amegadzie, BY ;
Hanning, CR ;
Jones, C ;
Kurdyla, JT ;
McNulty, DE ;
Drake, FH ;
Gowen, M ;
Levy, MA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12517-12524
[2]   HUMAN CATHEPSIN O2, A NOVEL CYSTEINE PROTEASE HIGHLY EXPRESSED IN OSTEOCLASTOMAS AND OVARY MOLECULAR-CLONING, SEQUENCING AND TISSUE DISTRIBUTION [J].
BROMME, D ;
OKAMOTO, K .
BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1995, 376 (06) :379-384
[3]  
CHAUHAN SS, 1993, J BIOL CHEM, V268, P1039
[4]  
COOPER DN, 1990, HUM GENET, V85, P55
[5]   INHIBITION OF BONE-RESORPTION IN CULTURE BY INHIBITORS OF THIOL PROTEINASES [J].
DELAISSE, JM ;
EECKHOUT, Y ;
VAES, G .
BIOCHEMICAL JOURNAL, 1980, 192 (01) :365-368
[6]   INVIVO AND INVITRO EVIDENCE FOR THE INVOLVEMENT OF CYSTEINE PROTEINASES IN BONE-RESORPTION [J].
DELAISSE, JM ;
EECKHOUT, Y ;
VAES, G .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 125 (02) :441-447
[7]   A comprehensive genetic map of the human genome based on 5,264 microsatellites [J].
Dib, C ;
Faure, S ;
Fizames, C ;
Samson, D ;
Drouot, N ;
Vignal, A ;
Millasseau, P ;
Marc, S ;
Hazan, J ;
Seboun, E ;
Lathrop, M ;
Gyapay, G ;
Morissette, J ;
Weissenbach, J .
NATURE, 1996, 380 (6570) :152-154
[8]   Cathepsin K, but not cathepsins B, L, or S, is abundantly expressed in human osteoclasts [J].
Drake, FH ;
Dodds, RA ;
James, IE ;
Connor, JR ;
Debouck, C ;
Richardson, S ;
LeeRykaczewski, E ;
Coleman, L ;
Rieman, D ;
Barthlow, R ;
Hastings, G ;
Gowen, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12511-12516
[9]   TOULOUSE-LAUTRECS DIAGNOSIS - REPLY [J].
FREY, J .
NATURE GENETICS, 1995, 11 (04) :363-363
[10]   WHAT DWARFED TOULOUSE-LAUTREC [J].
FREY, JB .
NATURE GENETICS, 1995, 10 (02) :128-130